{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T22:05:02Z","timestamp":1779919502032,"version":"3.53.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007801","name":"Fundaci\u00f3n S\u00e9neca","doi-asserted-by":"publisher","award":["21886\/PI\/22"],"award-info":[{"award-number":["21886\/PI\/22"]}],"id":[{"id":"10.13039\/100007801","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"Horizon 2020","doi-asserted-by":"publisher","award":["843615"],"award-info":[{"award-number":["843615"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI21\/00174"],"award-info":[{"award-number":["PI21\/00174"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Espa\u00f1a Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jtha.2024.10.005","type":"journal-article","created":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T06:08:34Z","timestamp":1729145314000},"page":"210-221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Novel insights into antithrombin deficiency enabled by mass spectrometry-based precision diagnostics"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4520-7385","authenticated-orcid":false,"given":"Mirjam","family":"Kruijt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Eugenia","family":"de la Morena-Barrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Corral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christa M.","family":"Cobbaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3737-3807","authenticated-orcid":false,"given":"L. Renee","family":"Ruhaak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2024.10.005_bib1","doi-asserted-by":"crossref","first-page":"33202","DOI":"10.18632\/oncotarget.26059","article-title":"Biochemical and cellular consequences of the antithrombin p.Met1? mutation identified in a severe thrombophilic family","volume":"9","author":"Navarro-Fern\u00e1ndez","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.jtha.2024.10.005_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24732","article-title":"Analysis of phenotype and gene mutation in three pedigrees with inherited antithrombin deficiency","volume":"36","author":"Li","year":"2022","journal-title":"J\u00a0Clin Lab Anal"},{"key":"10.1016\/j.jtha.2024.10.005_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12959-022-00443-6","article-title":"Identification and characterization of two SERPINC1 mutations causing congenital antithrombin deficiency","volume":"21","author":"Wang","year":"2023","journal-title":"Thromb J"},{"key":"10.1016\/j.jtha.2024.10.005_bib4","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1160\/TH16-11-0866","article-title":"High levels of latent antithrombin in plasma from patients with antithrombin deficiency","volume":"117","author":"de la Morena-Barrio","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.005_bib5","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1152\/ajplegacy.1939.125.4.683","article-title":"The inhibition of blood clotting: an unidentified substance which acts in conjunction with heparin to prevent the conversion of prothrombin into thrombin","volume":"125","author":"Brinkhous","year":"1939","journal-title":"Am J Physiol-Legacy Content"},{"key":"10.1016\/j.jtha.2024.10.005_bib6","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1055\/s-0038-1656297","article-title":"Inherited antithrombin deficiency causing thrombophilia","volume":"13","author":"Egeberg","year":"1965","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.005_bib7","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1055\/s-0044-1786807","article-title":"Thrombophilia screening: not so straightforward","volume":"50","author":"Moore","year":"2024","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2024.10.005_bib8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1055\/s-0038-1625983","article-title":"Risk of venous thrombosis in antithrombin deficiency: a systematic review and Bayesian meta-analysis","volume":"44","author":"Croles","year":"2018","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2024.10.005_bib9","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.3390\/ijms23031821","article-title":"Inherited thrombophilia in the era of direct oral anticoagulants","volume":"23","author":"Khider","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtha.2024.10.005_bib10","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1182\/blood.2019002927","article-title":"How I treat patients with hereditary antithrombin deficiency","volume":"134","author":"Pabinger","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.10.005_bib11","doi-asserted-by":"crossref","first-page":"7101","DOI":"10.1182\/bloodadvances.2023010177","article-title":"American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing","volume":"7","author":"Middeldorp","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2024.10.005_bib12","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3324\/haematol.2016.156000","article-title":"Tailoring of medical treatment: hemostasis and thrombosis towards precision medicine","volume":"102","author":"Di Minno","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2024.10.005_bib13","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1160\/TH16-08-0635","article-title":"Thrombotic risk according to SERPINC1 genotype in a large cohort of subjects with antithrombin inherited deficiency","volume":"117","author":"Alhenc-Gelas","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.005_bib14","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.thromres.2015.03.013","article-title":"Antithrombin heparin binding site deficiency: a challenging diagnosis of a not so benign thrombophilia","volume":"135","author":"Orlando","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.10.005_bib15","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1182\/blood.2021014708","article-title":"Two SERPINC1 variants affecting N-glycosylation of Asn224 cause severe thrombophilia not detected by functional assays","volume":"140","author":"de la Morena-Barrio","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.10.005_bib16","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/ajh.26413","article-title":"Molecular and clinical characterization of transient antithrombin deficiency: a new concept in congenital thrombophilia","volume":"97","author":"Bravo-P\u00e9rez","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2024.10.005_bib17","doi-asserted-by":"crossref","first-page":"4493","DOI":"10.1021\/pr501038g","article-title":"Recent advances of proteomics applied to human diseases","volume":"13","author":"Thongboonkerd","year":"2014","journal-title":"J\u00a0Proteome Res"},{"key":"10.1016\/j.jtha.2024.10.005_bib18","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/S0140-6736(00)03214-1","article-title":"Proteomics: new perspectives, new biomedical opportunities","volume":"356","author":"Banks","year":"2000","journal-title":"The Lancet"},{"key":"10.1016\/j.jtha.2024.10.005_bib19","first-page":"868","article-title":"Antithrombin deficiency as a still underdiagnosed thrombophilia: a primer for internists","volume":"130","author":"Bravo-P\u00e9rez","year":"2020","journal-title":"Pol Arch Intern Med"},{"key":"10.1016\/j.jtha.2024.10.005_bib20","first-page":"611","article-title":"Five challenging cases of hereditary antithrombin deficiency characterized by thrombosis or complicated pregnancy","volume":"13","author":"Roberts","year":"2022","journal-title":"J\u00a0Blood Med"},{"key":"10.1016\/j.jtha.2024.10.005_bib21","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s11239-020-02090-y","article-title":"Thrombophilia screening revisited: an issue of personalized medicine","volume":"49","author":"Colucci","year":"2020","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2024.10.005_bib22","first-page":"499","article-title":"Antithrombin deficiency and thrombosis: a wide clinical scenario reported in a single institution","volume":"14","author":"Marco-Rico","year":"2023","journal-title":"J\u00a0Blood Med"},{"key":"10.1016\/j.jtha.2024.10.005_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.100079","article-title":"Antithrombin diagnostics by mass spectrometry: development and analytical validation of a next-generation test","volume":"7","author":"Kruijt","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.005_bib24","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1515\/cclm-2017-1111","article-title":"Detecting molecular forms of antithrombin by LC-MRM-MS: defining the measurands","volume":"56","author":"Ruhaak","year":"2018","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jtha.2024.10.005_bib25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/jth.15553","article-title":"Unraveling a borderline antithrombin deficiency case with quantitative mass spectrometry","volume":"20","author":"Kruijt","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.005_bib26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cca.2013.09.018","article-title":"From biomarkers to medical tests: the changing landscape of test evaluation","volume":"427","author":"Horvath","year":"2014","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jtha.2024.10.005_bib27","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.161430","article-title":"Full-length antithrombin frameshift variant with aberrant C-terminus causes endoplasmic reticulum retention with a dominant-negative effect","volume":"7","author":"Bravo-P\u00e9rez","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.jtha.2024.10.005_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymgme.2018.11.003","article-title":"The challenge of CDG diagnosis","volume":"126","author":"Francisco","year":"2019","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.jtha.2024.10.005_bib29","article-title":"Identification of regulatory mutations in SERPINC1 affecting vitamin D response elements associated with antithrombin deficiency","volume":"11","author":"Toderici","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jtha.2024.10.005_bib30","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1111\/jth.13372","article-title":"Hypoglycosylation is a common finding in antithrombin deficiency in the absence of a SERPINC1 gene defect","volume":"14","author":"de la Morena-Barrio","year":"2016","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.005_bib31","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1160\/TH11-10-0701","article-title":"Regulatory regions of SERPINC1 gene: identification of the first mutation associated with antithrombin deficiency","volume":"107","author":"de la Morena-Barrio","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.005_bib32","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.3390\/ijms24055023","article-title":"Usefulness and limitations of multiple ligation-dependent probe amplification in antithrombin deficiency","volume":"24","author":"Cifuentes","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtha.2024.10.005_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.107606","article-title":"Coagulation abnormalities in a prospective cohort of 50 patients with PMM2-congenital disorder of glycosylation","volume":"139","author":"De Graef","year":"2023","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.jtha.2024.10.005_bib34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/jimd.12024","article-title":"International clinical guidelines for the management of phosphomannomutase 2-congenital disorders of glycosylation: Diagnosis, treatment and follow up","volume":"42","author":"Altassan","year":"2019","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.jtha.2024.10.005_bib35","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1160\/TH15-11-0871","article-title":"Antithrombin Dublin (p.Val30Glu): a relatively common variant with moderate thrombosis risk of causing transient antithrombin deficiency","volume":"116","author":"Navarro-Fern\u00e1ndez","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.005_bib36","doi-asserted-by":"crossref","first-page":"6682","DOI":"10.1021\/bi9702492","article-title":"The oligosaccharide side chain on Asn-135 of alpha-antithrombin, absent in beta-antithrombin, decreases the heparin affinity of the inhibitor by affecting the heparin-induced conformational change","volume":"36","author":"Turk","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.jtha.2024.10.005_bib37","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0021-9258(18)89776-9","article-title":"Isolation and characterization of an antithrombin III variant with reduced carbohydrate content and enhanced heparin binding","volume":"260","author":"Peterson","year":"1985","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2024.10.005_bib38","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.thromres.2017.10.023","article-title":"Clinical and laboratory characteristics of antithrombin deficiencies: a large cohort study from a single diagnostic center","volume":"160","author":"Gindele","year":"2017","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.10.005_bib39","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ymgme.2013.02.006","article-title":"Thrombotic complications in patients with PMM2-CDG","volume":"109","author":"Linssen","year":"2013","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.jtha.2024.10.005_bib40","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1182\/blood-2012-01-406207","article-title":"Amelioration of the severity of heparin-binding antithrombin mutations by posttranslational mosaicism","volume":"120","author":"Mart\u00ednez-Mart\u00ednez","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.10.005_bib41","doi-asserted-by":"crossref","first-page":"13688","DOI":"10.1074\/jbc.M300062200","article-title":"Deletion of P1 arginine in a novel antithrombin variant (antithrombin London) abolishes inhibitory activity but enhances heparin affinity and is associated with early onset thrombosis","volume":"278","author":"Raja","year":"2003","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2024.10.005_bib42","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/cpt.1295","article-title":"Health care evolves from reactive to proactive","volume":"105","author":"Waldman","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jtha.2024.10.005_bib43","article-title":"Long-term management of pulmonary embolism: a review of consequences, treatment, and rehabilitation","volume":"11","author":"H\u00f8jen","year":"2022","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jtha.2024.10.005_bib44","first-page":"90","article-title":"How to analyze the diagnostic performance of a new test? Explained with illustrations","volume":"14","author":"Dhamnetiya","year":"2022","journal-title":"J\u00a0Lab Physicians"},{"key":"10.1016\/j.jtha.2024.10.005_bib45","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1111\/jth.12364","article-title":"Type II antithrombin deficiency caused by a founder mutation Pro73Leu in the Finnish population: clinical picture","volume":"11","author":"Puurunen","year":"2013","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.005_bib46","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/jth.13252","article-title":"Founder effect is responsible for the p.Leu131Phe heparin-binding-site antithrombin mutation common in Hungary: phenotype analysis in a large cohort","volume":"14","author":"Gindele","year":"2016","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.005_bib47","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abq3202","article-title":"Gene editing of human iPSCs rescues thrombophilia in hereditary antithrombin deficiency in mice","volume":"14","author":"Tang","year":"2022","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jtha.2024.10.005_bib48","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/ijc.28940","article-title":"Personalised cancer medicine","volume":"137","author":"Jackson","year":"2015","journal-title":"Int J Cancer"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624006111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624006111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T03:45:32Z","timestamp":1738208732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783624006111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1538783624006111"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2024.10.005","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel insights into antithrombin deficiency enabled by mass spectrometry-based precision diagnostics","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2024.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}